Ann: CEO & Executive Chairman increases IMU shareholding, page-4

Sydney, Australia, 25 May 2021: Imugene Ltd (ASX:IMU), an immuno-oncology company, is pleased to
advise the following exercise of unlisted options:
• Executive Chairman, Paul Hopper has exercised 25 million options at an exercise value of
$1,070,000,
• Managing Director and CEO, Leslie Chong has exercised 36.2 million options at an exercise
value of $1,517,000 with a remaining 13.8 million options to be exercised by Ms Chong in the
near future.
Additional announcements for the exercise of options will follow including Appendix 3B, 2A as well as
Appendix 3Y for the Change of Directors Interest.
The company will use the additional funds to further the research and development activities.
Phillip Hains